Dakota Community Bank & Trust’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,809
Closed -$157 131
2023
Q3
$157 Hold
1,809
﹤0.01% 126
2023
Q2
$1.01K Sell
1,809
-2,171
-55% -$1.92K 0.01% 128
2023
Q1
$4.54K Buy
+3,980
New +$4.78K 0.03% 98

Other funds holding RVLP

Dakota Community Bank & Trust's RVLP Position: Q4 2023 in Review

Dakota Community Bank & Trust sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 1,809 shares — an estimated $157 sold.

Dakota Community Bank & Trust first reported a position in RVLP in Q1 2023 and held it in 3 quarters. The position peaked at $4.54K in Q1 2023. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

  • Dakota Community Bank & Trust reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Dakota Community Bank & Trust sold 1,809 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $157.
  • Dakota Community Bank & Trust first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2023 and held it in 3 quarters.
  • Dakota Community Bank & Trust's RVL Pharmaceuticals plc Ordinary Shares position peaked at $4.54K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on Dakota Community Bank & Trust's 13F filing for Q4 2023, filed 10 Jan 2024.